Gilles Atlan

Gilles is Vice President of NF2 BioSolutions for 3 years. Gilles has 20 years of experience in the software industry and currently works for SAP Labs as an Innovation Manager. Gilles’s daughter, Karen, was diagnosed with NF2 at age of 6 due to a juvenile cataract. Today Karen is 15 and already has undergone 4 surgeries (2 eyes, and  2 vestibular schwannomas removed). Gilles grew up in France, lived near San Francisco for more than 10 years, and today is based in Israel. He holds a BSc in Mechanical Engineering from Ben Gurion University and an MSc in Computer Science from the University of Manchester. Gilles specializes in innovation methodologies and user engagement and is applying these skills to grow and develop NF2 BioSolutions (NBS). Gilles strongly believes that novel therapies like cell/gene and immunotherapies are the best hope for a better future for NF2 patients. In 4 years, NF2 BioSolutions jumpstarted and sponsored more than 6 labs in the USA, UK and France.